Abilia Ltd
@abilialtd
Swavesey, Cambridgeshirehttp://www.abilia.com/uk Medical Equipment ManufacturingOverview
About Abilia Ltd
Abilia gives people the power to become independent and take control of their daily lives.
Based on more than 40 years of experience and supported by research evidence, we know that our assistive technology helps people to have structure over their day, communicate, control appliances in their home and call for attention.
We believe that everyone should have the same opportunities to participate in society on their own terms, and are passionate about enabling people access to a more fulfilling life.
Abilia develops, manufactures and sells aids for individuals with disabilities in the areas of communication, cognition and environment control & alarm. We have offices in Sweden, Norway, and the UK, and export our products to another 20 countries. Abilia is a merger of the four companies Gewa, Falck Igel, Handitek and Toby Churchill. Our turnover currently amounts to about SEK 200 million. Abilia is owned by MedCap, a Nordic investor that focuses on established Life Science companies with significant development potential. MedCap has been part-owner in the former GEWA AB since 2007.
Based on more than 40 years of experience and supported by research evidence, we know that our assistive technology helps people to have structure over their day, communicate, control appliances in their home and call for attention.
We believe that everyone should have the same opportunities to participate in society on their own terms, and are passionate about enabling people access to a more fulfilling life.
Abilia develops, manufactures and sells aids for individuals with disabilities in the areas of communication, cognition and environment control & alarm. We have offices in Sweden, Norway, and the UK, and export our products to another 20 countries. Abilia is a merger of the four companies Gewa, Falck Igel, Handitek and Toby Churchill. Our turnover currently amounts to about SEK 200 million. Abilia is owned by MedCap, a Nordic investor that focuses on established Life Science companies with significant development potential. MedCap has been part-owner in the former GEWA AB since 2007.